Sander Florman
Overview
Explore the profile of Sander Florman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
1553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu E, Tabrizian P, Gutierrez J, Hoteit M, Ghaziani T, Zhou K, et al.
Hepatology
. 2025 Jan;
PMID: 39808828
Background And Aims: Patients with HCC meeting United Network for Organ Sharing (UNOS)-downstaging (DS) criteria have excellent post-liver transplantation (LT) outcomes. Studies on HCC beyond UNOS-DS criteria ("All-Comers" [AC]) have...
2.
Durand C, Massie A, Florman S, Liang T, Rana M, Friedman-Moraco R, et al.
N Engl J Med
. 2024 Oct;
391(15):1390-1401.
PMID: 39413376
Background: Kidney transplantation from donors with human immunodeficiency virus (HIV) to recipients with HIV is an emerging practice. It has been performed since 2016 under the U.S. congressional HIV Organ...
3.
dEscamard V, Kadian-Dodov D, Ma L, Lu S, King A, Xu Y, et al.
Nat Cardiovasc Res
. 2024 Sep;
3(9):1098-1122.
PMID: 39271816
Fibromuscular dysplasia (FMD) is a poorly understood disease affecting 3-5% of adult females. The pathobiology of FMD involves arterial lesions of stenosis, dissection, tortuosity, dilation and aneurysm, which can lead...
4.
Rutledge S, Nathani R, Wyatt B, Eschbach E, Trivedi P, Kerznerman S, et al.
Hepatol Commun
. 2024 Aug;
8(9).
PMID: 39167426
Background: Severe alcohol-associated hepatitis (AH) that is nonresponsive to corticosteroids is associated with high mortality, particularly with concomitant acute-on-chronic liver failure (ACLF). Most patients will not be candidates for liver...
5.
van Leeuwen L, Irizar H, Kim-Schluger L, Florman S, Akhtar M
J Hepatol
. 2024 Aug;
81(6):e298-e300.
PMID: 39094744
No abstract available.
6.
Bekki Y, Rocha C, Myers B, Wang R, Smith N, Tabrizian P, et al.
Clin Transplant
. 2024 May;
38(5):e15336.
PMID: 38762783
Background: Individual events during donation after circulatory death (DCD) procurement, such as hypotensive or hypoxic warm ischemia, or circulatory arrest are all a part of donor warm ischemia time (dWIT),...
7.
Rocha C, Di Norcia J, Tabrizian P, Di Renzo C, Amodeo S, Bekki Y, et al.
HPB (Oxford)
. 2024 May;
26(8):1007-1021.
PMID: 38735814
Background: Assess impact of direct-acting antivirals introduction on outcomes after liver resection for hepatocellular carcinoma. Methods: 391 patients (1991-2021) treated with resection for hepatocellular carcinoma on Hepatitis C background were...
8.
Khaim R, Todd R, Rosowicz A, Shapiro R, Florman S, Kim-Schluger L, et al.
Clin Transplant
. 2024 Feb;
38(2):e15267.
PMID: 38380716
Race-inclusive estimated glomerular filtration rate (eGFR) could contribute to racial disparity in access to kidney transplantation. The Organ Procurement and Transplantation Network (OPTN) issued a policy allowing waiting time modification...
9.
Holzner M, Mazzaferro V, Droz Dit Busset M, Aldrighetti L, Ratti F, Hasegawa K, et al.
Ann Surg Oncol
. 2024 Feb;
31(7):4397-4404.
PMID: 38334851
Background: Recurrence of intrahepatic cholangiocarcinoma (ICC) after liver resection (LR) remains high, and optimal therapy for recurrent ICC is challenging. Herein, we assess the outcomes of patients undergoing repeat resection...
10.
Motter J, Hussain S, Brown D, Florman S, Rana M, Friedman-Moraco R, et al.
Transplantation
. 2023 Nov;
108(3):759-767.
PMID: 38012862
Background: Kidney transplant (KT) candidates with HIV face higher mortality on the waitlist compared with candidates without HIV. Because the HIV Organ Policy Equity (HOPE) Act has expanded the donor...